No image available
No image available
No image available
No image available
No image available
The invention relates to plasmid expression vector encoding human interleukin 12 (IL-12) and its use for human cancer gene therapy using electroporation or any other applications. The said plasmid carries the human IL-12 fusion gene under the transcriptional control of human promoter of the CDKN1A (p21) gene. The plasmid carries no antibiotic resistance genes.
No image available
No image available
No image available
No image available
No image available